Consultation on low value turnover exemption (LVT) scheme
Published
Related content
-
TGA opens consultation on the use of prescription opioids for pain
The TGA has issued a discussion paper on the use and misuse of prescription strong opioids, such as oxycodone, and whether there is a need for specific regulatory responses -
New transparency measures for prescription medicines
The Australian Government has given approval to proceed with two measures to enhance transparency for prescription medicines -
Review of the Narcotic Drugs Act 1967
Invitation to comment on discussion paper now published